Ramucirumab plus paclitaxel as a second-line treatment for advanced gastric or gastro-oesophageal junction cancer
Crossref DOI link: https://doi.org/10.1038/nrgastro.2014.174
Published Online: 2014-10-07
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2014-10-07
Article History
First Online: 7 October 2014